CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Cancer Network
Original article

<![CDATA[Taking The First Steps for a Personalized Lung Cancer Vaccine Trial]]>

Trial StartNeutral
AI Analysis

Summary

Physician Dan Costin, MD counsels the first patient enrolled in the INTerpath-014 trial comparing a personalized mRNA vaccine against observation in lung cancer patients.

Clinical Trial Data

Importance:4/10
Sentiment:
0.00
personalized medicinemRNA vaccinelung cancerclinical trialoncology
Related Companies

Read the original article

Published by Cancer Network on October 6, 2026 6:00 PM

Read Original